Fred BodimerBy Fred Bodimer

ST. LOUIS (KMOX) – A local infectious diseases specialist is closely following the progress of the two Americans who were given an experimental Ebola serum before being brought back to the United States.

Saint Louis University’s Dr. Daniel Hoft says this serum hasn’t been used in humans beforeonly in monkeys with Ebolabut it appears to be working on the two American victims.

“The goal is for it to block the Ebola virus that’s in the body from infecting the cells,” he says. “And if it efficiently does that, then it will reduce the total amount of virus that’s in the body, and that will in turn result in reduction in symptoms.”

Reportedly, that’s what it is doing right now. Hoft says he has no problem with allowing the untested serum to be given to humans since there was no other option.

He just says further testing must be done on it to see if it is safe or can be improved.

Human testing on an Ebola vaccine is set to begin next month.

(TM and © Copyright 2014 CBS Radio Inc. and its relevant subsidiaries. CBS RADIO and EYE Logo TM and Copyright 2014 CBS Broadcasting Inc. Used under license. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed.)



Leave a Reply

Please log in using one of these methods to post your comment:

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

More From CBS St. Louis

Download The App

Listen Live